For active immunisation of cats from eight weeks of age against: -feline calicivirosis to reduce clinical signs. -feline viral rhinotracheitis to reduce clinical signs and viral excretion. -feline panleucopaenia to prevent leucopenia and to reduce clinical signs. -feline leukaemia to prevent persistent viraemia and clinical signs of the related disease. -Onset of immunity: 3 weeks after the primary vaccination for the panleucopaenia and leukaemia components, and 4 weeks after the primary vaccination for the calicivirus and rhinotracheitis virus components. -After the primary vaccination course, the duration of immunity lasts for one year for all components. -Following a first booster vaccination one year after the primary vaccination course, a duration of immunity of 3 years has been demonstrated for the leukaemia component. Subcutaneous use. Reconstitute one dose of lyophilisate with one dose of solvent, shake gently and administer immediately. Administer subcutaneously one dose of the veterinary medicinal product according to the following regimen of vaccination. Primary vaccination: -first injection in kittens from 8 weeks of age -second injection 3 or 4 weeks later Maternally derived antibodies can negatively influence the immune response to vaccination. In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age. Revaccination: Following a first booster vaccination one year after the primary vaccination course, subsequent vaccinations can be performed at intervals of three years for the leukaemia component. In this case, since annual revaccination is required for calcivirus, rhinotracheitis virus and panleucopenia virus components, a single dose of Feligen RCP can be used annually. This vaccine can be used as a booster for kittens or cats previously vaccinated with FELIGEN RCP and LEUCOGEN separately.
Availability: Out of Stock - on backorder and will be dispatched once in stock.
